Shankar Prasan, Vijay Bhavya, Rahman Mahima, Anand Kimi, Nampoothiri Vasudevan
Department of Rasayana Tantra, I-AIM Healthcare Center, The University of Trans-Disciplinary Health Sciences and Technology, Bangalore, Karnataka, India.
Center for Community Health, Clinical Research, and Education, I-AIM Healthcare Center, The University of Trans-Disciplinary Health Sciences and Technology, Bangalore, Karnataka, India.
Case Reports Hepatol. 2024 Nov 27;2024:1176751. doi: 10.1155/crhe/1176751. eCollection 2024.
Liver cirrhosis is an advanced stage of abnormal fibrogenesis of tissues that causes liver injuries. Though cirrhosis can be managed by etiological parameters, its long-term reversal is still a question. Ayurveda system of medicine diagnoses liver disease under "Kamala" and "Udara" with promising outcomes of treatment. This case series discusses three cases of liver cirrhosis where internal Ayurvedic medications and external therapies including "Panchakarma" (a treatment approach of detoxifying and rejuvenating) resulted in effective management of the disease. Three cases of decompensated liver cirrhosis were treated at an Ayurveda hospital. Relevant examinations and investigations were done, and patients were monitored at regular intervals. Patients were treated with Ayurvedic therapies and were monitored for changes using standardized tools of assessment. In all three patients, there was an improvement in quality of life and a reduction in symptoms such as abdominal pain, transpyloric diameter, pedal oedema, and fatigue, as well as a significant reduction in liver function test parameters. Decompensated liver cirrhosis can be managed with an Ayurvedic treatment regimen that includes Ayurvedic medications, Panchakarma, along with a proper diet regimen with salt and fluid restrictions. This case series concludes that while cirrhosis is not completely reversible, fibrosis could be reversed. The support of modern medicine for monitoring and emergency care remains paramount. Furthermore, proper documentation of all the observations can help in assessing the outcomes of Ayurveda therapies and aid in developing integrative protocols for the management of liver cirrhosis in the future.
肝硬化是组织异常纤维生成导致肝损伤的晚期阶段。虽然肝硬化可通过病因学参数进行控制,但其长期逆转仍是个问题。阿育吠陀医学体系在“Kamala”和“Udara”范畴下诊断肝脏疾病,治疗效果良好。本病例系列讨论了三例肝硬化病例,其中阿育吠陀内服药物及包括“Panchakarma”(一种排毒和恢复活力的治疗方法)在内的外治疗法有效控制了病情。一家阿育吠陀医院对三例失代偿期肝硬化患者进行了治疗。进行了相关检查和调查,并定期对患者进行监测。采用阿育吠陀疗法对患者进行治疗,并使用标准化评估工具监测变化情况。在所有三名患者中,生活质量均有所改善,腹痛、经幽门直径、足部水肿和疲劳等症状减轻,肝功能测试参数也显著降低。失代偿期肝硬化可通过包括阿育吠陀药物、Panchakarma以及适当的限盐和限液饮食方案的阿育吠陀治疗方案进行控制。本病例系列得出结论,虽然肝硬化不能完全逆转,但纤维化可以逆转。现代医学在监测和急救方面的支持仍然至关重要。此外,对所有观察结果进行适当记录有助于评估阿育吠陀疗法的效果,并有助于未来制定肝硬化综合管理方案。